Automated Insulin Delivery

Exploring the Barriers to Uptake of Automated Insulin Delivery

December 4th 2021, 4:07pm

Article

Authors from the University of Colorado say factors from skin irritations, to cost, to lack of insurance coverage, to physician barriers have limited uptake of automated insulin delivery systems.

New Guidelines Offer Advice for Clinicians as Open-Source Automated Insulin Grows in Popularity

December 1st 2021, 4:00pm

Article

Clinicians should be willing to work with patients eager to try “do-it-yourself” insulin systems, but should also warn them of the risks, the guidelines state.

Study Finds Fully Closed-Loop Insulin System Outperforms Standard Insulin Therapy in T2D

November 27th 2021, 5:00pm

Article

An open-label randomized trial found patients using the closed-loop system had more time in their target glucose ranges.

Cynthia Rice Discusses JDRF's Progress in Making Automated Insulin Delivery More Available

November 19th 2021, 1:00pm

Video

Cynthia Rice, JDRF chief mission strategy officer, discusses how JDRF is working to make automated insulin delivery available and affordable for everyone.

Closed-Loop Insulin System Is Cost-effective in Type 1 Diabetes, Analysis Says

November 15th 2021, 9:15pm

Article

Lower indirect costs and a lower incidence of serious complications offset the higher cost of the advanced hybrid closed-loop insulin system.

Cynthia Rice: Automated Insulin Delivery Coverage Is Modernizing the Medicare Program

November 14th 2021, 5:00pm

Video

Cynthia Rice, JDRF chief mission strategy officer, says Medicare coverage of continuous glucose monitors (CGMs) without requiring finger sticks takes a burden off people with type 1 diabetes.

Flash CGM Associated With Event Reduction in Nonintensive Diabetes Therapy

November 12th 2021, 5:00pm

Article

Analysis of the MarketScan database showed a strong association between flash continuous glucose monitoring (CGM) use and significant reductions in diabetes-related events and hospitalizations in a cohort of 10,282 adults with type 2 diabetes.

COVID-19 Led to Overall Drop in Prescribing of Insulin to Adults, Study Finds

November 11th 2021, 1:30pm

Article

Although the authors say their findings shed light on possible disruptions to insulin supply during COVID-19, they note they could not adjust for those with diabetes who died.

Dr Robert Gabbay on Eliminating "Old-Fashioned" Finger Stick Rule

November 2nd 2021, 4:55am

Video

Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association (ADA), talks about the "old-fashioned" finger stick requirement for continuous glucose monitoring.